Aziridine Mediated Peptide Ligation

氮丙啶介导的肽连接

基本信息

  • 批准号:
    1149327
  • 负责人:
  • 金额:
    $ 42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Continuing Grant
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-15 至 2016-08-31
  • 项目状态:
    已结题

项目摘要

With this award, the Chemical Synthesis Program of the Chemistry Division is funding Professor Philip Garner of the Department of Chemistry at Washington State University to explore the development of a new chemical strategy (aziridine mediated peptide ligation) for the union of unprotected peptide segments and modification of the resulting product at the ligation site. This two-stage process begins with the chemoselective Cu(II)-promoted coupling of an unprotected peptide thioacid and unprotected aziridinyl peptide under native conditions to give an initial product with a reactive aziridine ring embedded at a pre-determined site. The coupling reaction is followed by an aziridine ring-opening reaction to give the final ligation product. This project will address two important chemical ligation problems that remain to be solved: (1) the need to develop more general peptide ligation methodology that circumvents the N-terminal Cys requirement of native chemical ligation and (2) the need for chemical ligation methodology that enables the site-specific introduction of modifications during the ligation event. The technology resulting from this project could impact the fields of Biology, Medicine, and Nanotechnology. The educational component of this project will include training graduate students and undergraduate researchers, so as to prepare them for either academic or industrial careers in chemistry. An effort will be made to recruit students from underrepresented groups to work on this project.
通过这一奖项,化学部化学合成计划资助华盛顿州立大学化学系的菲利普·加纳教授探索一种新的化学策略(氮杂环丙氨酸介导的多肽连接)的开发,用于连接未受保护的多肽片段并在连接部位修饰结果产物。这一两步反应始于在天然条件下,铜(II)促进的未保护多肽硫代酸和未保护氮杂环肽的化学选择性偶联,得到初始产物,其反应性氮杂环嵌在预定的位置。偶联反应之后是氮杂环丙烷开环反应,得到最终的连接产物。该项目将解决两个有待解决的重要化学连接问题:(1)需要开发更通用的多肽连接方法,以绕过天然化学连接的N-末端半胱氨酸要求;(2)需要化学连接方法,使在连接事件期间能够针对特定部位引入修饰。该项目产生的技术可能会影响生物、医学和纳米技术领域。该项目的教育部分将包括培训研究生和本科生研究人员,为他们在化学领域的学术或工业职业做准备。将努力从代表性不足的群体中招募学生参与这一项目。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Philip Garner其他文献

Philip Garner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Philip Garner', 18)}}的其他基金

Glycoproteins via Chemoselective Ligation of Proteins and Glycans
通过蛋白质和聚糖的化学选择性连接形成糖蛋白
  • 批准号:
    1665274
  • 财政年份:
    2017
  • 资助金额:
    $ 42万
  • 项目类别:
    Standard Grant
Asymmetric Synthesis of Highly Functional Pyrrolidines
高功能吡咯烷的不对称合成
  • 批准号:
    0813316
  • 财政年份:
    2007
  • 资助金额:
    $ 42万
  • 项目类别:
    Continuing Grant
Asymmetric Synthesis of Highly Functional Pyrrolidines
高功能吡咯烷的不对称合成
  • 批准号:
    0553313
  • 财政年份:
    2006
  • 资助金额:
    $ 42万
  • 项目类别:
    Continuing Grant
US-Turkey Cooperative Research: Development of Catalytic Asymmetric Azomethine Ylide Cycloaddition Reactions
美国-土耳其合作研究:催化不对称偶氮甲碱叶立德环加成反应的进展
  • 批准号:
    0242964
  • 财政年份:
    2003
  • 资助金额:
    $ 42万
  • 项目类别:
    Standard Grant
Asymmetric Synthesis with Chiral Heteroalkyl Radicals
手性杂烷基自由基的不对称合成
  • 批准号:
    0111831
  • 财政年份:
    2001
  • 资助金额:
    $ 42万
  • 项目类别:
    Continuing Grant
Asymmetric Synthesis with Chiral Heteroalkyl Radicals
手性杂烷基自由基的不对称合成
  • 批准号:
    9616632
  • 财政年份:
    1997
  • 资助金额:
    $ 42万
  • 项目类别:
    Continuing Grant

相似海外基金

Osmotic Regulation of a Peptide Ligand-Mediated Signaling
肽配体介导的信号传导的渗透调节
  • 批准号:
    10714344
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
Development of retroviral replicating vector-mediated liver-expressed iron-regulating peptide hormone, hepcidine gene therapy for esophageal cancer.
开发逆转录病毒复制载体介导的肝脏表达的铁调节肽激素、食道癌的铁碱基因疗法。
  • 批准号:
    23K08184
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dissecting stress modulation of pnVTA nociceptin peptide-mediated approach-avoidance behavior
剖析 pnVTA 伤害感受肽介导的趋避行为的应激调节
  • 批准号:
    10676589
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
Peptide-Mediated Enhancement of Akt During Resuscitation and Reperfusion
复苏和再灌注过程中肽介导的 Akt 增强
  • 批准号:
    10534999
  • 财政年份:
    2022
  • 资助金额:
    $ 42万
  • 项目类别:
Discovering the Mechanism of Action of a peptide drug, OPT101, that targets CD40 mediated inflammation in type 1 diabetes
发现肽药物 OPT101 的作用机制,该药物针对 1 型糖尿病中 CD40 介导的炎症
  • 批准号:
    10345075
  • 财政年份:
    2022
  • 资助金额:
    $ 42万
  • 项目类别:
Discovering the Mechanism of Action of a peptide drug, OPT101, that targets CD40 mediated inflammation in type 1 diabetes
发现肽药物 OPT101 的作用机制,该药物针对 1 型糖尿病中 CD40 介导的炎症
  • 批准号:
    10589075
  • 财政年份:
    2022
  • 资助金额:
    $ 42万
  • 项目类别:
Peptide-Mediated Enhancement of Akt During Resuscitation and Reperfusion
复苏和再灌注过程中肽介导的 Akt 增强
  • 批准号:
    10843727
  • 财政年份:
    2022
  • 资助金额:
    $ 42万
  • 项目类别:
COATs: Collagen-mimetic peptide and therapeutic gene-modified collagens for cell-mediated healing of diabetic foot ulcers
COAT:胶原模拟肽和治疗性基因修饰胶原,用于细胞介导的糖尿病足溃疡愈合
  • 批准号:
    10459594
  • 财政年份:
    2021
  • 资助金额:
    $ 42万
  • 项目类别:
Refining our understanding of antimicrobial peptide mediated disruption of the Klebsiella pneumoniae capsule
加深我们对抗菌肽介导的肺炎克雷伯菌荚膜破坏的理解
  • 批准号:
    10474519
  • 财政年份:
    2021
  • 资助金额:
    $ 42万
  • 项目类别:
Refining our understanding of antimicrobial peptide mediated disruption of the Klebsiella pneumoniae capsule
加深我们对抗菌肽介导的肺炎克雷伯菌荚膜破坏的理解
  • 批准号:
    10283340
  • 财政年份:
    2021
  • 资助金额:
    $ 42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了